Clinical Trials List
2009-10-01 - 2011-12-31
Phase III
Terminated6
-
Trial Applicant
Orient EuroPharma Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- 張源清 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzeon-jye Chiou Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Shen Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林璟宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 羅偉忠 Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張源清 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
586 participants
